| Literature DB >> 30344904 |
Charlotte Courtens1, Martijn Risseeuw1, Guy Caljon2, Paul Cos2, Serge Van Calenbergh1.
Abstract
Two classes of prodrugs of a fosmidomycin surrogate were synthesized and investigated for their ability to inhibit in vitro growth of P. falciparum and M. tuberculosis. To this end, a novel efficient synthesis route was developed involving a cross metathesis reaction as a key step. Alkoxyalkyl prodrugs show decent antimalarial activities, but acyloxybenzyl prodrugs proved to be the most interesting and show enhanced antimalarial and antitubercular activity. The most active antimalarial analogues show low nanomolar IC50 values.Entities:
Year: 2018 PMID: 30344904 PMCID: PMC6187408 DOI: 10.1021/acsmedchemlett.8b00223
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345